Verano Holdings (VRNO) Accounts Payables (2021 - 2026)
Verano Holdings (VRNO) reported Accounts Payables of $29.0 million for Q1 2026, down 36.21% year-over-year from $45.4 million in Q1 2025, and down 25.24% quarter-over-quarter from $38.7 million in Q4 2025.
Verano Holdings (VRNO) Accounts Payables (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Accounts Payables data on file, last reported at $29.0 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $29.0 million, down 36.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.0 million (down 36.21% YoY), and the FY2025 annual result was $38.7 million, down 2.98% from the prior year.
- Accounts Payables declined to $29.0 million in Q1 2026 per VRNO's latest filing, from $38.7 million in the prior quarter.
- Over five years, Accounts Payables peaked at $60.8 million in Q2 2022 and troughed at $25.2 million in Q2 2024.
- A 5-year average of $38.3 million and a median of $39.2 million in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables tumbled 42.91% in 2023, then soared 60.37% in 2025.
- A 5-year view of Accounts Payables shows it stood at $40.5 million in 2022, then dropped by 22.76% to $31.3 million in 2023, then climbed by 27.64% to $39.9 million in 2024, then retreated by 2.98% to $38.7 million in 2025, then fell by 25.24% to $29.0 million in 2026.
- Business Quant data shows VRNO's Accounts Payables at $29.0 million in Q1 2026, $38.7 million in Q4 2025, and $42.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 28.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.96 Mn |
| Dec 31, 2025 | 38.74 Mn |
| Sep 30, 2025 | 42.32 Mn |
| Jun 30, 2025 | 39.67 Mn |
| Mar 31, 2025 | 45.40 Mn |
| Dec 31, 2024 | 39.93 Mn |
| Sep 30, 2024 | 42.49 Mn |
| Jun 30, 2024 | 25.20 Mn |
| Mar 31, 2024 | 28.31 Mn |
| Dec 31, 2023 | 31.28 Mn |
| Sep 30, 2023 | 31.02 Mn |
| Jun 30, 2023 | 34.73 Mn |
| Mar 31, 2023 | 30.52 Mn |
| Dec 31, 2022 | 40.50 Mn |
| Sep 30, 2022 | 52.21 Mn |
| Jun 30, 2022 | 60.83 Mn |
| Dec 31, 2021 | 45.17 Mn |